Regne Unit -
anglès -
MHRA (Medicines & Healthcare Products Regulatory Agency)
raloxifene 60mg tablets
teva uk ltd - raloxifene hydrochloride - tablet - 60mg
Regne Unit -
anglès -
MHRA (Medicines & Healthcare Products Regulatory Agency)
raloxifene 60mg tablets
a a h pharmaceuticals ltd - raloxifene hydrochloride - tablet - 60mg
Regne Unit -
anglès -
MHRA (Medicines & Healthcare Products Regulatory Agency)
raloxifene 60mg tablets
dr reddy's laboratories (uk - raloxifene hydrochloride - tablet - 60mg
Regne Unit -
anglès -
MHRA (Medicines & Healthcare Products Regulatory Agency)
raloxifene 60mg tablets
de pharmaceuticals - raloxifene hydrochloride - tablet - 60mg
Regne Unit -
anglès -
MHRA (Medicines & Healthcare Products Regulatory Agency)
raloxifene 60mg tablets
mawdsley-brooks & company ltd - raloxifene hydrochloride - tablet - 60mg
Regne Unit -
anglès -
MHRA (Medicines & Healthcare Products Regulatory Agency)
raloxifene 60mg tablets
mylan - raloxifene hydrochloride - tablet - 60mg
Regne Unit -
anglès -
MHRA (Medicines & Healthcare Products Regulatory Agency)
raloxifene 60mg tablets
somex pharma - raloxifene hydrochloride - tablet - 60mg
Regne Unit -
anglès -
MHRA (Medicines & Healthcare Products Regulatory Agency)
raloxifene 60mg tablets
bristol laboratories ltd - raloxifene hydrochloride - tablet - 60mg
Israel -
anglès -
Ministry of Health
raloxifene teva
teva israel ltd - raloxifene hydrochloride - tablets - raloxifene hydrochloride 60 mg - raloxifene - - treatment of osteoporosis in post menopausal women.- prevention of osteoporosis in post menopausal women.- reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis. - reduction in risk of invasive breast cancer in postmenopausal women at high risk for invasive breast cancer.
Aràbia Saudita -
anglès -
SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء
evista 60 mg f-c tablets film-coated tablet
spimaco - raloxifene - film-coated tablet - 60 mg